Delivery Order SPE2DB22D2206-SPE2DB23FJC87

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $96
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for 4561691936 LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for the delivery of this pharmaceutical product to a facility in Conshohocken, Pennsylvania. Performance will take place from August 3rd to August 4th, 2023, with the Defense Logistics Agency as the funding agency. No subcontractors or set...
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for 4561888031 LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and calls for the delivery of pharmaceutical products to a Defense Logistics Agency location in Conshohocken, Pennsylvania. No set aside designation or subcontracting details were provided. The order is funded by the Defense Logistics Agency and supports...
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for LEUCOVORIN CAL 500 MG/50 ML VL 50ML under a firm fixed price contract. The order is to be fulfilled by Amerisourcebergen's Corporate Office Division facility located in Conshohocken, Pennsylvania by July 14, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract...
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for LEUCOVORIN CAL 500 MG/50 ML VL 50ML under a firm fixed price contract. The order is to be performed in Conshohocken, Pennsylvania by the prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division. Funding is provided by the Defense Logistics Agency to supply this pharmaceutical product in support of Department of Defense programs. The period of performance is August 3, 2023...
The Defense Logistics Agency awarded a delivery order valued at approximately $62,000 to Amerisourcebergen Drug Corporation for LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The firm fixed price order calls for delivery of the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 15, 2023, with performance beginning the previous day. Amerisourcebergen will serve as the prime contractor, with the Defense Logistics Agency as the funding agency. As a key distributor of medical...
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for LEUCOVORIN CAL 500 MG/50 ML VL 50ML under a firm fixed price contract. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by August 22, 2023 in support of the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the United States military...
The Defense Logistics Agency awarded a $1,148.18 firm fixed price delivery order to Amerisourcebergen Drug Corp for LEUCOVORIN CAL 500 MG/50 ML VL 50ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 27, 2023 under the terms of the contract. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support in both peacetime...
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for 4561534399 LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The firm fixed price order is being fulfilled under the prime contractor's corporate office division from its facility in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support its medical supply needs. No set aside designation or subcontractors are indicated. The single day period of performance from July 18...
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for LEUCOVORIN CAL 500 MG/50 ML VL 50ML under a firm fixed price contract. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the solicitation or any overarching contract vehicles. The prime contractor will deliver the pharmaceutical products to the...
The Defense Logistics Agency awarded a $61,880 delivery order to Amerisourcebergen Drug Corporation for 4561694938 LEUCOVORIN CAL 500 MG/50 ML VL 50ML. This firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the pharmaceutical product to DLA locations from August 3 to August 4, 2023. Amerisourcebergen will perform the order from its facility in Conshohocken, Pennsylvania and no subcontractors were identified. The Defense Logistics Agency...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FJC87
    Delivery Order

The Defense Logistics Agency awarded a $96,360 delivery order to Amerisourcebergen Drug Corporation for 4561473789 LEUCOVORIN CAL 500 MG/50 ML VL 50ML. The firm fixed price order is being fulfilled under the prime contractor's Corporate Office Division from its facility in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support the Department of Defense's medical supply needs. No set aside designation or subcontractors are indicated. This order for the pharmaceutical product will be completed by July 13, 2023 to meet customer requirements.

Generated 12/23/23, 3:44 PM